Introduction
Moderate or severe tricuspid regurgitation (TR) is frequently observed in patients with left-sided heart disease and have been associated with poor prognosis if left untreated. 1 Patients with prior leftsided valve surgery and patients with associated comorbidities that increase the operative risk and who develop significant TR over time are deemed not operable and treated medically. Recent emerging percutaneous transcatheter therapies for the tricuspid valve may expand the treatment options beyond optimal medical therapy alone. 2 In addition, these novel techniques may potentially enable concomitant transcatheter tricuspid valve repair during transcatheter procedures for the aortic or mitral valve. Currently available transcatheter treatment options for TR include the bicuspidalization of the tricuspid valve using sutures, the implantation of systems that cinch the tricuspid annulus, a spacer system positioned within the valve filling the leaflet coaptation gap, and the heterotopic implantation of transcatheter valves in the caval veins. [3] [4] [5] [6] Comprehensive 3-dimensional imaging plays a key role for the planning and periprocedural assistance of transcatheter tricuspid valve repair. Of particular importance are the structures that have a spatial relationship with the tricuspid valve annulus such as the right coronary artery (RCA). The course of the RCA through the right atrioventricular groove and the distance to the tricuspid valve annulus may vary. [7] [8] [9] Computed tomography (CT) enables detailed characterization of the spatial relationship between the RCA and the tricuspid valve annulus which is pivotal for preventing RCA impingement during percutaneous tricuspid valve annulus procedures. 2 Furthermore, CT provides geometrical information of the right ventricle (RV) relative to the tricuspid valve annulus facilitating the implantation of a spacer system, and by depicting the inferior vena cava, CT can assist the sizing of caval valves. However, at this early stage, there are no established guidelines on how to image the patients with significant TR who may be candidates for transcatheter tricuspid valve repair. Accordingly, the aim of present study was to perform a comprehensive anatomical evaluation of the tricuspid valve using CT providing data on the spatial relationship between the RCA and the tricuspid valve annulus, the RV, and the inferior vena cava dimensions in patients with and without significant TR in order to determine the potential role of CT for the planning of the transcatheter tricuspid valve repair techniques.
Methods Patients
A total of 250 patients clinically referred for CT prior to transcatheter aortic valve replacement (TAVR) were included. Patients with pacemaker or implantable cardioverter-defibrillator leads and patients whose CT images were of insufficient quality for evaluation of the spatial relationship between the tricuspid valve annulus and the RCA (n ¼ 24) were excluded from current analysis. Patients with organic TR were also excluded. The spatial anatomic relationships between the tricuspid valve annulus and the RCA and the dimensions of the inferior vena cava were assessed and compared between patients with moderate or severe functional TR (!3þ) vs. patients with mild or no functional TR (<3þ). TR was assessed with transthoracic echocardiography. Clinical, echocardiographic, and CT data were prospectively collected in the departmental electronic clinical files (EPD vision version 11.3.26.0; Leiden, The Netherlands) and retrospectively analysed.
Computed tomography acquisition
A 320-slice multi-detector CT scanner (AquilionOne, Toshiba Medical Systems, Tochigi-ken, Japan) with a collimation of 320 Â 0.5 mm and a rotation time of 350 ms was used. Tube voltage and current varied from 100-135 kV and 200-580 mA, depending on the patient's body mass index. When indicated, oral b-blockers were administered to patients with heart rates >65 beats per minute after careful evaluation of the patient's hemodynamic condition, taking the aortic valve stenosis into consideration. Based on the patients' body weight, ionic contrast medium (Ultravist 370, Bayer, Whippany, NJ, USA) was infused in the antecubital vein in three phases: 60-80 ml contrast with a flow-rate of 5.0-6.0 ml/s, followed by a 20 ml mixture of 1:1 contrast: saline and 25 ml of saline. Initiation of scanning was synchronized to the arrival of the contrast material in the left ventricle using automated peak enhancement detection with a threshold of þ180 Hounsfield Units. A whole volume of 16 cm coverage was used. Triggered to the electrocardiogram, the entire cardiac cycle was prospectively imaged. The CT data were reconstructed at each 10% of the RR interval and additional at 30-35% and 75% for systole and diastole. The reconstructions were transferred to an external workstation (Vitrea 2, Vital Images, Plymouth, Minnesota) for off-line image analysis. anatomical relationship between the RCA and the tricuspid valve annulus should be assessed due to the risk of impingement of the RCA by the suture pledgets or the anchoring system. 4, 6 The mid-diastolic phase volume rendered reconstructions, the 2-and 4-chamber long-axis and the shortaxis views were evaluated to determine the course and position (superior/inferior/same level) of the RCA relative to the tricuspid valve annulus (Figures 1 and 2 ). In the short-axis view of the tricuspid valve annulus, the distance between the RCA and the annulus was measured at the level of the anterior and posterior tricuspid leaflets insertions, if the RCA coursed at the same level ( Figure 2) . If the RCA was superior or inferior relative to the annulus at the level of the anterior or posterior tricuspid leaflets insertions, the distance between the RCA and the annulus was measured in the 4-chamber long-axis view ( Figure 3) .
Computed tomography analysis
Distance from the tricuspid valve annulus to the right ventricular apex and tricuspid valve annulus geometry
For devices that directly interact with the tricuspid valve leaflets such as the Forma Repair System (Edwards Lifesciences, Irvine, California), the tricuspid valve annulus dimensions and the distance from the annulus to the right ventricular apex should be evaluated. 3 The long-axis 4-chamber view was used for measurement of the maximal distance between the tricuspid valve annulus and the right ventricular apex ( Figure 4) . The tricuspid valve annulus geometry was analysed in the end-systolic phase as previously described. 10 In the reconstructed short-axis view of the tricuspid valve annulus, the maximal antero-posterior and septal-lateral diameter of the annulus were measured and the perimeter and area were assessed by planimetry. 10 
Inferior vena cava
Assessment of the vena cava dimensions and the distance from the junction of right atrium and inferior vena cava to the first hepatic vein are important parameters for evaluation of heterotopic caval valve implantation.
11
The dimensions of the inferior vena cava were assessed during mid-diastole at two levels: at the transition level with the right atrium and at the level of the first hepatic vein ( Figure 5 ). 11 From the axial view, the multi-planar reformation planes were oriented along the right ventricular apex and the coronary sinus. On the resultant single oblique sagittal and coronal views, the 
. 11 The maximum and minimum diameter, perimeter and area of the inferior vena cava were assessed at this level ( Figure 5 ). These measurements were repeated on the double oblique transverse plane at the level of the first hepatic vein ( Figure 5 ). The distance between the levels of transition of the inferior vena cava with the right atrium and the first hepatic vein was also measured ( Figure 5 ).

Echocardiography
Transthoracic, 2-dimensional Doppler echocardiography was performed with commercially available ultrasound systems equipped with 3.5 MHz or M5S transducers (Vivid-7 or E9, General Electric Vingmed, Horten, Norway). Data were digitally stored in cine-loop format in the departmental echocardiographic database allowing off-line analysis (EchoPac 112.0.1, GE Medical Systems, Horten, Norway). TR grade was assessed according to current recommendations using a multi-parametric approach and classified as none or trivial (0-1þ), mild (2þ), moderate (3þ), or severe (4þ). 12, 13 The pulmonary artery pressure was estimated as the sum of the right ventricular pressure gradient (derived from the maximum velocity of the TR jet using the modified Bernoulli equation) and the right atrial pressure (estimated according to the size and respiratory changes of the inferior vena cava). 14 
Statistical analysis
Continuous data were presented as mean 6 standard deviation or as median (interquartile range), and categorical data as frequency and percentage. Differences between patients with and without TR !3þ were compared with the unpaired Student t-test and the v 2 test for continuous and categorical data, respectively. Statistical tests were two-sided and P-values <0.05 were considered statistical significant. These analyses were performed with SPSS software version 20.0 (Armonk, NY: IBM Corp).
Figure 4
Distance from the tricuspid valve annulus to the right vetnricular apex. In the long-axis 4-chamber view, the distance from the tricuspid valve annulus to the right ventricular apex was assessed.
Figure 5
Assessment of the inferior vena cava dimensions. In the orthogonal axial view, the multi-planar reformation planes were oriented along the right ventricular apex and the coronary sinus (A). Subsequently, in the single oblique sagittal (B) and coronal (C) views, the multi-planar reformation planes were aligned along the transition of right atrium and inferior vena cava parallel to the basal part of the coronary sinus to reconstruct a double oblique transverse plane of the inferior vena cava at the entrance into the right atrium (D). The maximal and minimal diameter, perimeter, and area of the inferior vena cava were assessed (D). Thereafter, the multi-planar reformation planes were positioned to the lower level of the inferior vena cava and the distance between the inferior vena cava at that point and the first hepatic vein was measured (E). Next, using the single oblique sagittal (F) and coronal (G) views, a double oblique transverse plane of the inferior vena cava was reconstructed to measure the maximal and minimal diameter, perimeter and area (H). 
Results
Baseline clinical and echocardiographic characteristics of overall population are shown in Table 2 . Of the 250 patients, 52.4% were male and the mean age was 80 6 7.2 years. Patients with TR !3þ (n ¼ 40) were more likely to have atrial fibrillation (45.0% vs. 17.1%, P < 0.001) and lower left ventricular ejection fraction (51 6 16% vs. 56 6 14%, P ¼ 0.044) compared to the patients with TR <3þ (n ¼ 210). Furthermore, patients with TR !3þ had a higher estimated pulmonary artery pressure (45 6 13 mmHg vs. 34 6 11 mmHg, P < 0.001) and were more likely to present with concomitant moderate-severe mitral regurgitation (42.5% vs. 15.2%, P < 0.001) compared to those with TR <3þ.
Comprehensive computed tomography analysis of tricuspid valve annulus, right coronary artery, and inferior vena cava
Relationship of theright coronary artery to the tricuspid valve annulus In total, 214 (85.6%) patients had a right dominant coronary system, 28 (11.2%) patients had a left dominant system, and 8 (3.2%) patients had a balanced system. The frequency of coronary dominance did not significantly differ between patients with and without TR !3þ (P ¼ 0.429). The results of the analysis of the anatomical relationship between the RCA and the tricuspid valve annulus are shown in Table 3 . The distribution of these horizontal distances from the tricuspid valve annulus to the RCA in the overall population is shown in Figure 6 . When the RCA had a superior or inferior position relative to the tricuspid annulus, the mean vertical distance from the RCA to the anterior and posterior tricuspid leaflet levels was 4.4 6 1.8 mm and 4.6 6 2.3 mm, respectively. Patients with TR <3þ showed more frequently a course of the RCA superior to the tricuspid annulus at the levels of the anterior and the posterior tricuspid leaflet insertions compared with their counterparts (12.4 vs. 0%, P ¼ 0.019). There were no differences between groups for the remaining parameters ( Table 3) .
Tricuspid valve annulus geometry and distance from the annulus to the right ventricular apex The geometrical characteristics of the tricuspid valve are shown in Table 3 . Patients with TR !3þ had larger dimensions of the tricuspid valve annulus compared to patients with TR <3þ (Table 3) . Furthermore, the distance between the tricuspid valve annulus and the right ventricular apex was larger in the patients with TR !3þ compared with their counterparts (74 6 11 mm vs. 69 6 9 mm, P ¼ 0.001). 
Inferior vena cava dimensions
The geometrical characteristics of the inferior vena cava are shown in Table 3 . At the transition level with the right atrium, the dimensions of the inferior vena cava of the patients with TR !3þ were larger than in those with TR <3þ (e.g. area 674 mm 2 6 193 vs. 588 6 172 mm 2 , P ¼ 0.005) ( Table 3) . At the level of the first hepatic vein, the dilatation of the inferior vena cava in patients with TR !3þ was larger than in patients with TR <3þ (557 6 176 mm 2 vs. 507 6 132 mm 2 , P ¼ 0.047) ( Table 3 ). The distance between the junction with the right atrium and the first hepatic vein was comparable between both groups ( Table 3) .
Implications of computed tomography measurements for transcatheter options for tricuspid regurgitation
Relationship of theright coronary artery to the tricuspid valve annulus A maximal distance between the anterior part of the tricuspid valve annulus (at the level of the anterior leaflet insertion) and the RCA of 2.0 mm was observed in 15 patients (7.4%), of whom 10 (6.0%) had TR <3þ and 5 (13.5%) patients TR !3þ (P ¼ 0.118). For these patients, procedures implanting suture pledgets or an anchoring system at the annulus underlying the anterior tricuspid leaflet may be associated with an increased risk of RCA impingement. A maximal distance between the posterior part of the tricuspid valve annulus (at the level of the posterior leaflet insertion) of 2.0 mm was observed in 56 patients (31.5%), of whom 45 (30.4%) patients showed TR <3þ and 11 (36.7%) patients TR !3þ (P ¼ 0.501). For these patients, the use of suture pledgets at this level may increase the risk of RCA impingement.
Inferior vena cava dimensions
Heterotopic caval valve implantation has been performed using a custom designed prosthetic valve tailored to the dimensions of the landing zone within the inferior vena cava, and a commercially available balloon expandable valve (29 mm SAPIEN XT; Edwards Lifesciences, Irvine, CA, USA) that was originally designed for the treatment of aortic stenosis. 5 Currently, the largest size of the balloon expandable valve (SAPIEN 3; Edwards Lifesciences, Irvine, CA, USA) is 29 mm which may cover a cross-sectional area of 680 mm 2 (nominal expanded area) and a length of 22.5 mm. 15 In 71 (28.4%) patients, of whom 52 (25.2%) had TR <3þ and 18 (45.0%) TR !3þ (P ¼ 0.011), the cross-sectional area of the inferior cava exceeded 680 mm 2 at either the cavoatrial junction or at the level of the first hepatic vein (P ¼ 0.011) implicating the need for self-expandable stents for better apposition of the prosthesis. For 235 (94.0%) patients, of whom 197 (93.8%) had TR <3þ and 38 (95.0%) had TR !3þ, the length between the cavoatrial junction and the level of the first hepatic vein (P ¼ 0.771) was smaller than 22.5 mm. These findings would favour the use of custom made valves or a smaller commercially available prosthesis to avoid blockage of the first hepatic vein.
Discussion
The present study showed that CT provides comprehensive assessment of anatomy and geometry of the tricuspid valve apparatus prior to procedural planning of currently available percutaneous transcatheter tricuspid valve therapies. Particularly, the spatial relationship between the tricuspid valve annulus and RCA and exact measurements of the dimensions of tricuspid valve annulus and vena cava are important in the selection of patients who may be candidates for these procedures.
Prevalence of significant tricuspid regurgitation in high-surgical risk patients
Functional TR is an increasing problem in Western countries. 16 Left ventricular systolic and diastolic dysfunction, mitral and aortic valve disease, and chronic obstructive pulmonary disease are highly prevalent in the ageing population and are associated with increased pulmonary pressures and right ventricular afterload that may lead to functional TR. In addition, the use of pacemaker devices is increasing and the right ventricular pacing lead may interfere with the movement of the tricuspid valve leaflets causing functional TR. Finally, patients with previous left-sided heart valve surgery often develop significant TR; these patients are at high risk for repeat heart surgery. 17 These different pathophysiological situations lead to an increasing number of patients with significant TR and reduced survival if left untreated. [18] [19] [20] [21] The relatively high in-hospital mortality rates in reoperation for TR observed in these patients (10-25%) contributes to the low-surgical referral rate. 13 In addition, recent findings from the inoperable cohort of the PARTNER II trial, comprising 542 TAVR patients, showed that the prevalence of moderate or severe TR was 27% and was associated with reduced 1-year survival [hazard ratio of moderate or severe TR vs. none or mild TR ¼ 1.76 (1.14-2.70), P ¼ 0.01]. 22 The promising results of transcatheter aortic and mitral valve therapies in inoperable and high-risk surgical patients have prompted the development of transcatheter therapies for significant TR providing a therapeutic solution for an important unmet clinical need.
Computed tomography as key imaging technique for patient selection and procedural planning
For each of the currently available transcatheter tricuspid valve repair techniques, specific anatomical aspects should be taken into consideration to optimize the results and to minimize the complication risk. Accurate planning of the procedure with CT is of importance since this imaging technique provides information on the anatomical spatial relationship of the tricuspid valve apparatus and vena cava that echocardiography may not provide. In addition, CT may pave the path towards future developments in fusion imaging overlying the CT images onto fluoroscopy for further improvement in procedural guidance. Furthermore, current developments in 3-dimensional printing software can use CT data to recreate the tricuspid valve apparatus and permit accurate planning of the intervention, particularly in the field of congenital heart disease. 
Percutaneous tricuspid valve annulus reduction techniques
Impingement of the RCA is one of the most feared complications in these procedures. Injury to the RCA is a serious, but rare complication of surgical tricuspid valve annuloplasty. 7 The variability in distances between the tricuspid valve annulus and the RCA has been previously studied by Ueda et al. 9 The anatomical study of 44 normal human hearts, showed that the median nearest distance from the RCA to the base of the anterior tricuspid leaflet was 6.8 mm (range 5.9-11.0 mm) and to the posterior tricuspid leaflet 2.1 mm (2.0-4.0 mm). In the present study, including patients with and without significant TR, the distance between the RCA and the tricuspid valve measured with CT was larger at the insertion level of the anterior tricuspid leaflet whereas the RCA coursed more closely to the annulus at the level of the insertion of the posterior leaflet. These anatomical observations may have important implications for the Mitralign 6 and Tricinch 4 systems. With the Mitralign system, bicuspidalization of the tricuspid valve is achieved by positioning pledgeted sutures around the insertion points of the anterior and the posterior tricuspid leaflets, improving their coaptation and reducing the TR grade. 6 To safely perform this procedure, continuous monitoring with transesophageal echocardiography and demarcation of the RCA course with wires and angiography are needed. 6 For the Tricinch System, currently evaluated in the PREVENT (Percutanous Treatment of Tricuspid Valve Regurgitation with the Tricinch System) trial, 4 the distance from the insertion of the anterior tricuspid leaflet into the annulus to the RCA should be studied in advance. In this procedure, the tricuspid annulus dimensions are reduced by positioning of a corckscrew anchor at the anterior tricuspid leaflet that is connected through a Dacron band to a self-expandable stent implanted in the inferior vena cava. In the present study, CT analysis showed a less favourable course of the RCA ( 2.0 mm distance to the annulus) in 12.5% of the patients with TR !3þ at the anterior tricuspid leaflet and in 27.5% of the patients with TR !3þ at the posterior tricuspid leaflet. This has important implications for patient selection.
Spacing system to fill the tricuspid regurgitant orifice The Forma Repair System is an inflatable spacer device that is positioned within the regurgitant orfice area of the incompetent tricuspid valve providing a surface for native leaflet coaptation during systole. 3 Initial experience with this device has been derived from seven patients with severe TR who underwent this procedure without major safety issues and improvement in functional New York Heart Association class. 3 The inflatable spacer is attached to a rail and via the left axillary vein, the rail is attached with a steerable catheter in the right ventricular apex guided by 3-dimensional transoesophageal echocardiography and right ventriculography. 3 Currently, the spacer is available in a size of 12 or 15 mm and it has a fixed length of 42 mm. During the procedure, the most optimal leaflet to the spacer coaptation is achieved by positioning the spacer in the centre of the regurgitant orifice area perpendicular to the valve plane and this is assisted by 3-dimensional transoesophageal echocardiography. Nonetheless, the present study shows that CT may be of value for procedural planning by providing the interventionalist on forehand geometrical information of how the tricuspid valve annulus plane is oriented relative to the right ventricular apex facilitating catheter maneuvering during the procedure.
Heterotopic caval valve implantation
Accurate geometrical assessment of the right atriocaval junction, the vena cava, and of the distance to the first hepatic vein is pivotal for prosthesis sizing and the avoidance of hepatic vein obstruction during heterotopic caval valve implantation. This procedure has been successfully performed with a custom designed prosthesis and with a commercially available balloon expandable prosthesis used for TAVR procedures. 5, 23 The present CT analysis showed that in patients with TR !3þ, the mean cross-sectional area of the right atriocaval junction was 674 6 193 mm 2 whereas the mean distance between the right atriocaval junction and the first hepatic vein was 14.1 6 5.4 mm. These geometrical characteristics favour the use of a custom designed prosthesis for caval valve implantation as the largest commercially available balloon expandable prosthesis (the 29 mm SAPIEN 3, Edwards Lifesciences, Irvine, CA, USA) may cover a cross-sectional area of 680 mm but has a length of 22.5 mm. 15 Design of a customized caval valve prosthesis fitted to the vena cava geometry of the patient assessed by CT may provide the most favourable results.
Study limitations
Several limitations should be acknowledged. The number of patients with moderate or severe TR is relatively small. In addition, current CT data acquisition was performed for assessment of the aortic annulus dimensions and aorta. The contrast enhances the left chambers and coronary arteries. To ensure adequate and homogeneous contrast enhancement of the right heart, a slower contrast injection protocol and an earlier start of the scan would be preferred. 8 Nevertheless, the acquisition was performed with ECG-gating allowing us to reconstruct the images at different time points of the cardiac cycle ensuring good visualization of the RCA in relation with the tricuspid annulus. Currently, the minimal distance between the RCA to the tricuspid annulus for transcatheter annuloplasty devices has not yet been determined. Changes in tricuspid annulus dimensions across the cardiac cycle were not evaluated. These changes may be relevant in future developments of transcatheter systems that aim at implanting a transcatheter valve within the native tricuspid annulus. Changes in RCA position relative to the tricuspid annulus level across the cardiac cycle have been previously described. 8 However, for selection of patients with significant TR who may be candidates for current transcatheter therapies, these changes may not be important. The position of the RCA during the procedure should be monitored with invasive coronary angiography. Echocardiographic estimation of pulmonary systolic pressure in patients with severe TR may be problematic and, accordingly, current European Society of Cardiology guidelines on management of pulmonary hypertension recommend further evaluation with invasive assessment when the estimated pulmonary pressure exceeds 40 mmHg. 
Conclusions
Percutaneous transcatheter tricuspid valve therapy is an evolving treatment option for patients with significant TR deemed too fragile for open heart surgery. In addition, it may offer concomitant tricuspid valve repair for patients undergoing transcatheter treatment of aortic stenosis or mitral regurgitation who also have significant TR. However, current evidence for the efficacy and safety of this therapy is derived from preliminary data of first-in-man case reports and small series warranting more validation in larger prospective randomized trials. The analysis of CT datasets of the right atrioventricular complex of patients with significant TR may provide accurate insights for the size and 3-dimensional design of novel devices. So far, there are no established recommendations on how to evaluate patients who are candidates for these novel therapies. The present study proposes a first systematic approach to define the patient suitability for each device.
